Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
83.58
+2.79 (3.45%)
At close: Jun 15, 2026, 4:00 PM EDT
83.18
-0.40 (-0.48%)
After-hours: Jun 15, 2026, 7:15 PM EDT
Spyre Therapeutics Employees
Spyre Therapeutics had 112 employees as of March 31, 2026. The number of employees increased by 39 or 53.42% compared to the same quarter last year.
Employees
112
Change
39
Growth
53.42%
Revenue / Employee
n/a
Profits / Employee
-$1,327,705
Market Cap
7.26B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| PTC Therapeutics | 991 |
| ImmunityBio | 691 |
| Vaxcyte | 507 |
| TG Therapeutics | 399 |
| Immunovant | 315 |
| Apogee Therapeutics | 261 |
| Kymera Therapeutics | 253 |
SYRE News
- 6 hours ago - Spyre Therapeutics price target raised to $112 from $98 at BTIG - TheFly
- 13 hours ago - Spyre says bowel disease drug cuts inflammation in mid-stage trial - Reuters
- 13 hours ago - Spyre Therapeutics announces SKYLINE trial achieves primary endpoint - TheFly
- 14 hours ago - Spyre Announces Potential Best-in-Class SPY002 (anti-TL1A) Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients - GlobeNewsWire
- 4 days ago - Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Trends
- 7 days ago - Spyre Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 10 days ago - Spyre Therapeutics Announces Grants of Inducement Awards - GlobeNewsWire
- 11 days ago - Spyre Therapeutics price target raised to $115 from $102 at Deutsche Bank - TheFly